Novel anti-tumour activity of 2,3,5-trimethyl-6-(3-pyridylmethyl)-1,4- benzoquinone (CV-6504) against established murine adenocarcinomas (MAC).
about
The Janus-Faced Role of Antioxidants in Cancer Cachexia: New Insights on the Established ConceptsDecreased NADPH oxidase expression and antioxidant activity in cachectic skeletal muscle.Mechanism of the anti-tumour effect of 2,3,5-trimethyl-6-(3-pyridylmethyl) 1,4-benzoquinone (CV-6504).Lipoxygenase and Cyclooxygenase Pathways and Colorectal Cancer PreventionMetabolism and pharmacokinetics of the anti-tumour agent 2,3,5-trimethyl-6-(3-pyridylmethyl)1,4-benzoquinone (CV-6504).Common polymorphisms in 5-lipoxygenase and 12-lipoxygenase genes and the risk of incident, sporadic colorectal adenoma.
P2860
Novel anti-tumour activity of 2,3,5-trimethyl-6-(3-pyridylmethyl)-1,4- benzoquinone (CV-6504) against established murine adenocarcinomas (MAC).
description
1996 nî lūn-bûn
@nan
1996年の論文
@ja
1996年学术文章
@wuu
1996年学术文章
@zh-cn
1996年学术文章
@zh-hans
1996年学术文章
@zh-my
1996年学术文章
@zh-sg
1996年學術文章
@yue
1996年學術文章
@zh
1996年學術文章
@zh-hant
name
Novel anti-tumour activity of ...... murine adenocarcinomas (MAC).
@en
Novel anti-tumour activity of ...... murine adenocarcinomas (MAC).
@nl
type
label
Novel anti-tumour activity of ...... murine adenocarcinomas (MAC).
@en
Novel anti-tumour activity of ...... murine adenocarcinomas (MAC).
@nl
prefLabel
Novel anti-tumour activity of ...... murine adenocarcinomas (MAC).
@en
Novel anti-tumour activity of ...... murine adenocarcinomas (MAC).
@nl
P2093
P2860
P356
P1476
Novel anti-tumour activity of ...... murine adenocarcinomas (MAC).
@en
P2093
P2860
P2888
P304
P356
10.1038/BJC.1996.229
P407
P577
1996-05-01T00:00:00Z